Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma

CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases

(2011) Jianda Yuan et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Novel Strategies to Improve DNA Vaccine Immunogenicity

(2011) Cevayir Coban et al.   CURRENT GENE THERAPY

In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers

(2011) Sandhya Vasan et al.   PLoS One

Immunologic Response to Xenogeneic gp100 DNA in Melanoma Patients: Comparison of Particle-Mediated Epidermal Delivery with Intramuscular Injection

(2010) B. A. Ginsberg et al.   CLINICAL CANCER RESEARCH

Sipuleucel-T for prostate cancer: the immunotherapy era has commenced

(2010) Carlo Buonerba et al.   Expert Review of Anticancer Therapy

DNA vaccines: an historical perspective and view to the future

(2010) Margaret A. Liu   IMMUNOLOGICAL REVIEWS

Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines

(2010) Emanuela Romano et al.   JOURNAL OF CLINICAL ONCOLOGY

Xenogeneic Murine Tyrosinase DNA Vaccine for Malignant Melanoma of the Digit of Dogs

(2010) C.A. Manley et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Melanoma Immunotherapy

(2010) Shanthi Sivendran et al.   MOUNT SINAI JOURNAL OF MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Malignant Melanoma of the Skin: Long-term Follow-up and Time to First Recurrence

(2010) Annika M. Hohnheiser et al.   WORLD JOURNAL OF SURGERY

Systemic Therapy for Cutaneous Melanoma

(2009) Jonathan Treisman et al.   CLINICS IN PLASTIC SURGERY

Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses

(2009) Yun Lin et al.   CYTOTHERAPY

Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery

(2009) Simon R. Best et al.   VACCINE

Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma

(2008) Miguel-Angel Perales et al.   MOLECULAR THERAPY

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

(2008) J. Yuan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA